Preoperative Prediction for Periprosthetic Bone Loss and Individual Evaluation of Bisphosphonate Effect After Total Hip Arthroplasty Using Artificial Intelligence

Overview

Journal Bone Joint Res

Date 2024 Apr 17

PMID 38631686

Authors

Akira Morita

Yuta Iida

Yutaka Inaba

Taro Tezuka

Naomi Kobayashi

Hyonmin Choe

Hiroyuki Ike

Eiryo Kawakami

Affiliations

Soon will be listed here.

Abstract

Aims: This study was designed to develop a model for predicting bone mineral density (BMD) loss of the femur after total hip arthroplasty (THA) using artificial intelligence (AI), and to identify factors that influence the prediction. Additionally, we virtually examined the efficacy of administration of bisphosphonate for cases with severe BMD loss based on the predictive model.

Methods: The study included 538 joints that underwent primary THA. The patients were divided into groups using unsupervised time series clustering for five-year BMD loss of Gruen zone 7 postoperatively, and a machine-learning model to predict the BMD loss was developed. Additionally, the predictor for BMD loss was extracted using SHapley Additive exPlanations (SHAP). The patient-specific efficacy of bisphosphonate, which is the most important categorical predictor for BMD loss, was examined by calculating the change in predictive probability when hypothetically switching between the inclusion and exclusion of bisphosphonate.

Results: Time series clustering allowed us to divide the patients into two groups, and the predictive factors were identified including patient- and operation-related factors. The area under the receiver operating characteristic (ROC) curve (AUC) for the BMD loss prediction averaged 0.734. Virtual administration of bisphosphonate showed on average 14% efficacy in preventing BMD loss of zone 7. Additionally, stem types and preoperative triglyceride (TG), creatinine (Cr), estimated glomerular filtration rate (eGFR), and creatine kinase (CK) showed significant association with the estimated patient-specific efficacy of bisphosphonate.

Conclusion: Periprosthetic BMD loss after THA is predictable based on patient- and operation-related factors, and optimal prescription of bisphosphonate based on the prediction may prevent BMD loss.

References

Alm J, Makinen T, Lankinen P, Moritz N, Vahlberg T, Aro H . Female patients with low systemic BMD are prone to bone loss in Gruen zone 7 after cementless total hip arthroplasty. Acta Orthop. 2009; 80(5):531-7. PMC: 2823339. DOI: 10.3109/17453670903316801. View

Kunze K, Orr M, Krebs V, Bhandari M, Piuzzi N . Potential benefits, unintended consequences, and future roles of artificial intelligence in orthopaedic surgery research : a call to emphasize data quality and indications. Bone Jt Open. 2022; 3(1):93-97. PMC: 9047073. DOI: 10.1302/2633-1462.31.BJO-2021-0123.R1. View

Lisacek-Kiosoglous A, Powling A, Fontalis A, Gabr A, Mazomenos E, Haddad F . Artificial intelligence in orthopaedic surgery. Bone Joint Res. 2023; 12(7):447-454. PMC: 10329876. DOI: 10.1302/2046-3758.127.BJR-2023-0111.R1. View

Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung U, Kubota N . PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest. 2004; 113(6):846-55. PMC: 362117. DOI: 10.1172/JCI19900. View

Ye G, Gao H, Wang Z, Lin Y, Liao X, Zhang H . PPARα and PPARγ activation attenuates total free fatty acid and triglyceride accumulation in macrophages via the inhibition of Fatp1 expression. Cell Death Dis. 2019; 10(2):39. PMC: 6426939. DOI: 10.1038/s41419-018-1135-3. View

Khatod M, Inacio M, Dell R, Bini S, Paxton E, Namba R . Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry. Clin Orthop Relat Res. 2015; 473(11):3412-20. PMC: 4586196. DOI: 10.1007/s11999-015-4263-4. View

Nagoya S, Tateda K, Okazaki S, Kosukegawa I, Shimizu J, Yamashita T . Restoration of proximal periprosthetic bone loss by denosumab in cementless total hip arthroplasty. Eur J Orthop Surg Traumatol. 2018; 28(8):1601-1607. DOI: 10.1007/s00590-018-2223-x. View

Nuttall M, Gimble J . Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol. 2004; 4(3):290-4. DOI: 10.1016/j.coph.2004.03.002. View

Oba M, Inaba Y, Kobayashi N, Ike H, Tezuka T, Saito T . Effect of femoral canal shape on mechanical stress distribution and adaptive bone remodelling around a cementless tapered-wedge stem. Bone Joint Res. 2016; 5(9):362-9. PMC: 5017138. DOI: 10.1302/2046-3758.59.2000525. View

10.

Harris W . Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969; 51(4):737-55. View

11.

Durie B, Katz M, Crowley J . Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005; 353(1):99-102. DOI: 10.1056/NEJM200507073530120. View

12.

Liberman U, Weiss S, Broll J, Minne H, Quan H, Bell N . Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995; 333(22):1437-43. DOI: 10.1056/NEJM199511303332201. View

13.

Hayashi S, Hashimoto S, Kanzaki N, Kuroda R, Kurosaka M . Daily activity and initial bone mineral density are associated with periprosthetic bone mineral density after total hip arthroplasty. Hip Int. 2016; 26(2):169-74. DOI: 10.5301/hipint.5000320. View

14.

Gruen T, McNeice G, Amstutz H . "Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res. 1979; (141):17-27. View

15.

Shane E, Burr D, Ebeling P, Abrahamsen B, Adler R, Brown T . Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010; 25(11):2267-94. DOI: 10.1002/jbmr.253. View

16.

Morita A, Kobayashi N, Choe H, Tezuka T, Higashihira S, Inaba Y . Preoperative factors predicting the severity of BMD loss around the implant after Total hip Arthroplasty. BMC Musculoskelet Disord. 2021; 22(1):290. PMC: 7980352. DOI: 10.1186/s12891-021-04161-4. View

17.

Ugland T, Haugeberg G, Svenningsen S, Ugland S, Berg O, Pripp A . Less periprosthetic bone loss following the anterolateral approach to the hip compared with the direct lateral approach. Acta Orthop. 2017; 89(1):23-28. PMC: 5810828. DOI: 10.1080/17453674.2017.1387730. View

18.

Gurung B, Liu P, Harris P, Sagi A, Field R, Sochart D . Artificial intelligence for image analysis in total hip and total knee arthroplasty : a scoping review. Bone Joint J. 2022; 104-B(8):929-937. DOI: 10.1302/0301-620X.104B8.BJJ-2022-0120.R2. View

19.

Langenberger B, Schrednitzki D, Halder A, Busse R, Pross C . Predicting whether patients will achieve minimal clinically important differences following hip or knee arthroplasty. Bone Joint Res. 2023; 12(9):512-521. PMC: 10471446. DOI: 10.1302/2046-3758.129.BJR-2023-0070.R2. View

20.

Kan B, Zhao Q, Wang L, Xue S, Cai H, Yang S . Association between lipid biomarkers and osteoporosis: a cross-sectional study. BMC Musculoskelet Disord. 2021; 22(1):759. PMC: 8419899. DOI: 10.1186/s12891-021-04643-5. View